Hasselbalch Hans Carl

51PUBLICATIONS
123CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursRegenerative medicine (incl. stem cells)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Sep 25, 2026
JAK2V617F Mutation in Ischemic Stroke: Bridging Hematology and Stroke Neurology.

|Sep 01, 2026
High Prevalence of the JAK2V617F Mutation in Patients With Acute Coronary Syndrome.

|Aug 13, 2026
Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative Neoplasms.

|Apr 08, 2026
A paradigm shift in the treatment of patients with polycythemia vera. The initial early use of recombinant interferon-alpha.

Richard T Silver, Hans Carl Hasselbalch

|Feb 26, 2026
Prime time for the use of statins in MPNs: from comorbidity drugs to disease-modifying partners.

Hans Carl Hasselbalch

|Dec 23, 2025
Atrial Fibrillation in Philadelphia Chromosome-negative Myeloproliferative Neoplasms: Thromboinflammatory Crosstalk with a Focus on the NLRP3 Inflammasome.

Olga Demska, Marta Szandruk-Bender, Niels Eske Bruun

Pageof 9

Frequent Collaborators

32 joint publications

Vibe Skov

21 joint publications

Lasse Kjaer

16 joint publications

Ellervik Christina

16 joint publications

Morten Kranker Larsen